Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants
Globe Newswire•12/08/2026•21:45 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.